Development of new drug strategies in infrequent digestive tumors: esophageal, biliary tract, and anal cancers.

Capdevila, Jaume; Ramos, Francisco Javier; Macarulla, Teresa; Elez, Elena; Ruiz-Echarri, Manuel; Perez-Garcia, Jose; Tabernero, Josep

Capdevila, Jaume; Ramos, Francisco Javier; Macarulla, Teresa; Elez, Elena; Ruiz-Echarri, Manuel; Perez-Garcia, Jose; Tabernero, Josep.

Affiliation

Capdevila J; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.

Curr Opin Oncol ; 21(4): 374-80, 2009 Jul.

Article in En | MEDLINE | ID: mdl-19412097

Subject(s)

Digestive System Neoplasms/drug therapy; Angiogenesis Inhibitors/therapeutic use; Anus Neoplasms/blood supply; Anus Neoplasms/drug therapy; Anus Neoplasms/enzymology; Biliary Tract Neoplasms/blood supply; Biliary Tract Neoplasms/drug therapy; Biliary Tract Neoplasms/enzymology; Digestive System Neoplasms/blood supply; Digestive System Neoplasms/enzymology; Drug Delivery Systems; ErbB Receptors/antagonists & inhibitors; Esophageal Neoplasms/blood supply; Esophageal Neoplasms/drug therapy; Esophageal Neoplasms/enzymology; Humans; Neovascularization, Pathologic/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Digestive System Neoplasms Limits: Humans Language: En Journal: Curr Opin Oncol Journal subject: NEOPLASIAS Year: 2009 Type: Article Affiliation country: Spain

Fulltext

XML

PubMed Links

Search on Google